Schedule 13G ownership disclosure

Collegium Pharmaceutical Inc

Common stock, par value $0.001 per share · CUSIP: 19459J104

Event date: 2026-09-30

Filing-level shares
1,514,310
Percent of class
4.7%
  • PRINCIPAL GLOBAL INVESTORS

    Shares: 1,514,310 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769734-26-000057
Form type
SCHEDULE 13G/A
Filer
COLLEGIUM PHARMACEUTICAL, INC
CIK
CIK 1267565
Filed
Oct 29, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub